KX2-391

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

1 competitor in Bone-Metastatic, Castration-Resistant Prostate Cancer

Drug Information

Target Indication

Bone-Metastatic, Castration-Resistant Prostate Cancer

Clinical Trial

Last updated: 12/4/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

ATNX

Athenex, Inc.

Related Pipeline

Metastatic Breast Cancer